ECDC Warns of Rising Drug-Resistant Gonorrhoea in EU
The European Centre for Disease Prevention and Control (ECDC) is warning about an increase in gonorrhoea strains resistant to ceftriaxone, the primary antibiotic used for treatment. A growing number of European countries are reporting these drug-resistant cases. The ECDC highlights the urgent need for enhanced surveillance, prevention efforts, and research into new treatment options. This trend poses a significant public health threat across the Union.
A common STD is becoming harder to treat, raising public health concerns across Europe.